Publications by authors named "Simon Graber"

Claim this Profile
G
Genotype and transcript processing of the tumour necrosis factor receptor TNFRSF1A in epithelial cells: implications for survival in cystic fibrosis.
Alexander Uden, Inga Dunsche, Sabina Janciauskiene, Simon Gräber, Longhua Feng

EBioMedicine· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is malunion of the greater tuberosity after reverse shoulder arthroplasty in patients with complex proximal humerus fracture associated with worse clinical outcomes? A prospective cohort study.
Janic Fischer, JoEllen Welter, Nils Horn, Simon Graber, Hans-Christoph Pape

Arch Orthop Trauma Surg· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival-Adjusted FEV1 and BMI Percentiles for Patients with Cystic Fibrosis before the Era of Triple CFTR Modulator Therapy in Germany.
A Susanne Dittrich, Markus Dumke, Ferdinand Kapl, Philipp Schneider, Sabine Wege

Respiration· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors in patients with acute mesenteric ischemia-novel tools for determining patient outcomes.
Stefanie Sinz, Marcel A Schneider, Simon Graber, Hatem Alkadhi, Andreas Rickenbacher

Surg Endosc· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An optimized protocol for assessment of sputum macrorheology in health and muco-obstructive lung disease.
Mirjam Völler, Annalisa Addante, Hanna Rulff, Benjamin von Lospichl, Simon Y Gräber

Front Physiol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pneumatosis intestinalis in abdominal CT: predictors of short-term mortality in patients with clinical suspicion of mesenteric ischemia.
Simon D Graber, Stefanie Sinz, Matthias Turina, Hatem Alkadhi

Abdom Radiol (NY)· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CFTR Modulator Therapy with Lumacaftor/Ivacaftor Alters Plasma Concentrations of Lipid-Soluble Vitamins A and E in Patients with Cystic Fibrosis.
Olaf Sommerburg, Susanne Hämmerling, S Philipp Schneider, Jürgen Okun, Claus-Dieter Langhans

Antioxidants (Basel)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis